Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma

2019 ◽  
Vol 20 (10) ◽  
Author(s):  
Vidhya Karivedu ◽  
Amit L. Jain ◽  
Thomas J. Eluvathingal ◽  
Abhinav Sidana
Keyword(s):  
Positron Emission Tomography ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Positron Emission Tomography Imaging ◽  
Emission Tomography ◽  
Tomography Imaging ◽  
Positron Emission

scholarly journals The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

2014 ◽  
Vol 48 (3) ◽  
pp. 219-227 ◽  
Author(s):  
Carmelo Caldarella ◽  
Barbara Muoio ◽  
Maria Antonietta Isgrò ◽  
Emilio Porfiri ◽  
Giorgio Treglia ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Response Assessment ◽  
Emission Tomography ◽  
Positron Emission ◽  
Pet Ct

Abstract Background. Positron emission tomography-computed tomography (PET-CT) using fluorodeoxyglucose (FDG) is increasingly used in the evaluation of patients with advanced renal cell carcinoma (RCC), primarily for staging purposes. The aim of this paper is to perform a systematic review about the usefulness of PET-CT using FDG in response assessment after treatment with tyrosine-kinase inhibitors (TKIs) in patients with advanced RCC. Materials and methods. The scientific literature about the role of PET-CT using FDG in the assessment of response to treatment with TKIs in patients affected by advanced RCC was systematically reviewed. Results. Seven studies about the role of PET-CT using FDG in the response assessment after treatment with TKIs (essentially sunitinib and sorafenib) in advanced RCC were retrieved in full-text and analysed, to determine the predictive role of this morpho-functional imaging method on patient outcome. Conclusions. To date, the role of PET-CT using FDG in evaluating the response to TKIs in metastatic RCC patients is still not well defined, partly due to heterogeneity of available studies; however, PET-CT reveals potential role for the selection of patients undergoing therapy with TKIs. The use of contrast-enhanced PET-CT appears to be promising for a “multi-dimensional” evaluation of treatment response in these patients.

Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma

2003 ◽  
Vol 60 (12) ◽  
pp. 395-400 ◽  
Author(s):  
H. Jadvar ◽  
H.M. Kherbache ◽  
J.K. Pinski ◽  
P.S. Conti
Keyword(s):  
Positron Emission Tomography ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Emission Tomography ◽  
Positron Emission ◽  
Diagnostic Role

scholarly journals Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma

2021 ◽  
Vol 37 (2) ◽  
pp. 125
Author(s):  
Aneesh Srivastava ◽  
Rahul Jena ◽  
TusharAditya Narain ◽  
UdayPratap Singh
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Role of positron emission tomography computed tomography in screening metastasis of renal cell carcinoma

2017 ◽  
Vol 48 (3) ◽  
pp. 677-685
Author(s):  
Ahmad Hafez Ahmad Afifi ◽  
Eman Mohamad Ahmad ◽  
Ashraf Naguib Etaby ◽  
Mohamad Adel Atta ◽  
Sherif Farouk Elzawawi
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Emission Tomography ◽  
Positron Emission

The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation

PET Clinics ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. 45-53 ◽  
Author(s):  
Hari Menon ◽  
Chunxiao Guo ◽  
Vivek Verma ◽  
Charles B. Simone
Keyword(s):  
Positron Emission Tomography ◽  
Positron Emission Tomography Imaging ◽  
Emission Tomography ◽  
Target Delineation ◽  
Tomography Imaging ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document